Clinical outcomes

Response AssessmentVaccine N = 10DD + Vaccine N = 7All N = 17
PR1 (10 %)01 (6 %)
SD4 (40 %)4 (57 %)8 (47 %)
PD5 (50 %)3 (43 %)8 (47 %)
Time to Progression4.4 months4.9 months4.6 months

DD denileukin diftitox, PD progressive disease, PR partial response, SD stable disease